trending Market Intelligence /marketintelligence/en/news-insights/trending/ya6qg4peptv8flh8jgpcwg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

UniQure appoints 2 board members

Blog

JMP Securities is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

M&A rebound sparks optimism for near-term deal activity

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition


UniQure appoints 2 board members

Amsterdam-based gene therapy company uniQure NV appointed Robert Gut and David Meek to the board.

Gut is currently the chief medical officer for Versartis Inc. Meek has been the CEO of Ipsen SA since 2016.